Linagliptin - Latest Advances

Drug hypersensitivity: When systemic symptoms and pustules converge

Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Published: October 02, 2025

A clever evaluation of the antidiabetic medications linagliptin and empagliflozin in bulk and spiked urine samples.

Journal: Bioanalysis

Published: September 29, 2025

Bullous pemphigoid induced by linagliptin: a case series of 17 patients in a rare disease referral center.

Journal: Italian journal of dermatology and venereology

Published: September 24, 2025

Correction: Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats.

Journal: Scientific reports

Published: September 15, 2025

Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.

Journal: Journal of managed care & specialty pharmacy

Published: September 12, 2025

Correction to "Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial".

Journal: Diabetes, obesity & metabolism

Published: September 01, 2025

Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase.

Journal: BMJ open

Published: August 21, 2025

Comparison of the clinical efficacy of linagliptin with SGLT2 inhibitors in diabetic patients: A comparative cross-sectional study from Pakistan.

Journal: Pakistan journal of pharmaceutical sciences

Published: August 18, 2025

A metal-free synthesis of phosphoramidates via I--catalyzed oxidative coupling of anilines/amines with H-phosphonates.

Journal: Molecular diversity

Published: July 08, 2025

Cost Effectiveness of the 15 Drugs Selected for IPAY 2027 CMS Drug Price Negotiation.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: July 02, 2025

Targeting GLP-1 Signaling Ameliorates Cystogenesis in a Zebrafish Model of Nephronophthisis.

Journal: International journal of molecular sciences

Published: June 24, 2025

A novel RP-HPLC approach for simultaneous determination of dapagliflozin, linagliptin, and metformin in pharmaceutical formulations.

Journal: BMC chemistry

Published: June 11, 2025

Filters

Drug hypersensitivity: When systemic symptoms and pustules converge

Drug hypersensitivity: When systemic symptoms and pustules converge

A clever evaluation of the antidiabetic medications linagliptin and empagliflozin in bulk and spiked urine samples.

A clever evaluation of the antidiabetic medications linagliptin and empagliflozin in bulk and spiked urine samples.

Bullous pemphigoid induced by linagliptin: a case series of 17 patients in a rare disease referral center.

Bullous pemphigoid induced by linagliptin: a case series of 17 patients in a rare disease referral center.

Correction: Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats.

Correction: Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats.

Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.

Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.

Correction to "Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial".

Correction to "Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial".

Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase.

Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase.

Comparison of the clinical efficacy of linagliptin with SGLT2 inhibitors in diabetic patients: A comparative cross-sectional study from Pakistan.

Comparison of the clinical efficacy of linagliptin with SGLT2 inhibitors in diabetic patients: A comparative cross-sectional study from Pakistan.

A metal-free synthesis of phosphoramidates via I--catalyzed oxidative coupling of anilines/amines with H-phosphonates.

A metal-free synthesis of phosphoramidates via I--catalyzed oxidative coupling of anilines/amines with H-phosphonates.

Cost Effectiveness of the 15 Drugs Selected for IPAY 2027 CMS Drug Price Negotiation.

Cost Effectiveness of the 15 Drugs Selected for IPAY 2027 CMS Drug Price Negotiation.

Targeting GLP-1 Signaling Ameliorates Cystogenesis in a Zebrafish Model of Nephronophthisis.

Targeting GLP-1 Signaling Ameliorates Cystogenesis in a Zebrafish Model of Nephronophthisis.

A novel RP-HPLC approach for simultaneous determination of dapagliflozin, linagliptin, and metformin in pharmaceutical formulations.

A novel RP-HPLC approach for simultaneous determination of dapagliflozin, linagliptin, and metformin in pharmaceutical formulations.